NCT02858869
- Conditions
- Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +35 more
- Locations
-
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
Clinical trial condition
Melanoma of Unknown Primary
Explore clinical trials studying Melanoma of Unknown Primary. Study availability and eligibility vary by location and protocol.
6 public trials
0 recruiting studies
Melanoma of Unknown Primary trial results
NCT03033576
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, +3 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
NCT02129075
- Conditions
- Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +25 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
- Mount Sinai Hospital New York, United States
- Duke University Medical Center Durham, North Carolina, United States
Active, Not Recruiting
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
NCT01274338
- Conditions
- Melanoma, Melanoma of Unknown Primary, Neoplasms, +14 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Providence Hospital Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Alaska Regional Hospital Anchorage, Alaska, United States
Active, Not Recruiting
Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
NCT04462406
- Conditions
- Advanced Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, +8 more
- Locations
-
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
Active, Not Recruiting
A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma
NCT04708418
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Melanoma of Unknown Primary, +15 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States